MOUNJARO
THE NEW LICENSED, MHRA APPROVED, WEEKLY WEIGHT LOSS INJECTION.
INTRODUCTORY OFFER - £50 OFF YOUR FIRST PEN WITH CODE: FIRST50!
Mounjaro and WeGovy has replaced Saxenda, which is currently being phased out and discontinued. No more daily injections, Mounjaro is a weekly injection.
MOUNJARO
Discover Mounjaro (also know as Zepbound), an innovative treatment designed to support your weight management goals and foster a healthier lifestyle. Sanctioned by health regulatory bodies and recommended by medical experts, Mounjaro represents more than just medication—it's a stride towards better health.
Clinical trials have demonstrated that Mounjaro effectively promotes considerable weight loss when integrated with a low-calorie diet and regular exercise. Patients can lose up to 25% of their body weight overall. Research shows that users often see significant decreases in body weight, which is instrumental in boosting overall wellness and lowering the risk of diseases associated with obesity.
Mounjaro has been approved for use in people who are overweight or have obesity. Research has shown that its active ingredient, tirzepatide, may lead to greater weight loss compared to semaglutide, which is found in Wegovy.
COST:
2.5MG PEN- £190
5.0MG PEN- £190
7.5MG PEN- £209
10MG PEN- £209
12,5MG PEN- £229
15MG PEN- £229
WHAT IS MOUNJARO?
Mounjaro is a prescribed, licensed injectable medication used as part of a weight management program. It is appropriate for adults over the age of 18 with obesity, either with a Body Mass Index (BMI) of 30 or higher without associated medical problems, or for adults with at least one weight-related condition (such as sleep apnea, diabetes, high blood pressure), and a BMI of at least 27.
Mounjaro functions in conjunction with lifestyle modifications, which may include dietary changes, increased physical activity, and/or surgery.
Mounjaro is NOT suitable for women who are pregnant, breastfeeding, or actively trying to conceive. Certain individuals may not be suitable for this treatment. Please refer to our FAQ's below for complete information.
MOUNJARO DOSING SCHEDULE
DESIGNED FOR EASE
Mounjaro is available in six different strengths. The initial dose is 2.5 mg, administered weekly for one month. Each dosage is color-coded and delivered in a pen that contains four doses, sufficient for four weeks. Every four weeks, you increase your dosage gradually until you reach the maintenance dose of 15 mg. Mounjaro is approved for long-term usage and can be continued as long as it provides benefits—such as weight loss and maintenance—without causing severe side effects.
HOW DOES MOUNJARO COMPARE TO OTHER WEIGHT LOSS INJECTABLES?
MOUNJARO VERSUS WEGOVY
Mounjaro and WeGovyare both weight management medications that function similarly by mimicking the GLP-1 hormone, yet they are formulated with distinct active ingredients.
Mounjaror contains tirzepatide, while WeGovy includes semaglutide.
Mounjaro® contains an active ingredient known as tirzepatide, which targets two hormonal receptors—GIP and GLP-1. By mimicking these hormones, it helps suppress appetite, regulate blood sugar, and slow down the rate at which food exits the stomach, all of which contribute to weight loss.
On the other hand, the active ingredient in Wegovy® is semaglutide. It functions by imitating the GLP-1 receptor, leading to similar effects as mentioned above. However, unlike tirzepatide, semaglutide does not affect the GIP receptor.
Overall, while both medications provide effective pathways to weight management, Mounjaro has been shown to have superior efficacy to WeGovy.
CAN I SWITCH FROM WEGOVY TO MOUNJARO?
While the data indicates that Mounjaro® is more effective, this doesn't automatically suggest you should switch medications without careful consideration.
If you have been using Wegovy® for a while and are managing the side effects well, continuing with Wegovy® might be beneficial, particularly if it's yielding positive results. If you are considering a switch and have been prescribed by Sebastian Rose Medical Aesthetics,, please reach out to us for personalised guidance.
If you are not currently our patient, we can assist in facilitating the switch to Mounjaro® (if clinically appropriate) or continue supporting your treatment with Wegovy®. Additionally, a weight loss consultation will be required to proceed.
Our Partners
MOUNJARO FAQ'S
WHAT IS MOUNJARO?
Mounjaro® (tirzepatide) is a weekly injectable treatment designed for adults looking to lose weight. It is particularly effective for individuals with high body mass indexes (BMIs). Containing the active ingredient tirzepatide, Mounjaro® should be used in conjunction with healthy lifestyle adjustments, including increased physical activity and a calorie-reduced diet. Mounjaro® is also marketed under the name Zepbound. Unlike WeGovy, it is not yet recommended by the National Institute for Clinical Excellence (NICE) for weight loss management.
HOW DOES MOUNJARO WORK?
The active ingredient, tirzepatide, targets two hormone receptors, GIP and GLP-1. By mimicking these naturally occurring hormones, tirzepatide suppresses appetite, enhances blood sugar regulation, and slows the rate at which food exits the stomach. These effects collectively contribute to weight loss.
IS MOUNJARO LICENSED FOR WEIGHT LOSS?
Yes. Unlike Ozempic which is not licensed for weight loss, Mounjaro is licensed as a weight loss injectable treatment.
WHY SHOULD I CHOOSE MOUNJARO?
Mounjaro has demonstrated superior effects in clinical studies and clinical trials, and has demonstrated the highest level of weight loss in patients compared to other weight loss injectables or placebo.
Mounjaro is convenient, requiring only a once weekly injection.
AM I SUITABLE FOR MOUNJARO TREATMENT?
You may be suitable for treatment with Mounjaro if:
- You have a BMI of over 30
- You have a BMI of over 27, with at least one associated co-morbidity, such as sleep apnea, high blood pressure, diabetes, high cholesterol, etc
- You are willing to undergo associated lifestyle changes, such as sticking to a healthy / calorific reduced diet, and increased physical activity
CAN I GET MOUNJARO FREE ON THE NHS?
You cannot get Mounjaro for weight loss on the NHS. At the moment, Mounjaro is only available on the NHS for treatment of type 2 diabetes.
WHO IS NOT SUITABLE FOR MOUNJARO TREATMENT?
You are not suitable for Mounjaro treatment if:
- You are pregnant
- You are breastfeeding
- You are actively trying for a baby
- You are of childbearing age but are not using adequate contraception
- You are under the age of 18
- You are type I diabetic
- You are currently taking another type of weight loss injectable, such as WeGovy
- You have had a serious allergic reaction to semaglutide, or any of the ingredients in Mounjaro in the past
- You have ever had pancreatitis, that was directly caused or related to weight loss injectables
- You, or any member of your family, have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC)
- You have an endocrine system condition called Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
HOW LONG DOES MOUNJARO TAKE TO START WORKING?
Mounjaro starts to work straight away, and you ought to start feeling fuller after a few weeks. However, everyone responds to medicines in different ways, so there is not a set time for when you can expect to start to seeing results. It may take several weeks before the full appetite suppressant effects are noted. If you do not see any results within 6 weeks of taking Mounjaro, your medical practitioner may want to try an alternative treatment.
Clinical trials indicate that when used alongside physical activity, diet, and behavioural support, Mounjaro patient's can achieve up to a 25% reduction in their body weight after one year.
VERY COMMON SIDE EFFECTS
Very common: may affect more than 1 in 10 people. These usually go away over time.
- Hypoglycaemia1*when used with sulphonylurea or insulin
- diarrhoea
- feeling sick (nausea)
- being sick (vomiting)
- constipation
COMMON SIDE EFFECTS
Common: may affect up to 1 in 10 people
- Hypersensitivity reactions
- dizziness
- low blood pressure (hypotension) related events
- Abdominal pain
- Vomiting
- Dyspepsia
- Constipation
- Abdominal distention
- Burping
,- Flatulence
- Gastroesophageal reflux disease
- Hair loss (hair loss was reported in 4.7% of patients treated with tirzepatide and in 0.84% of patients treated with placebo)
- Fatigue
- Injection site reactions
- Increased heart rate
- Lipase increase
- Amylase decrease
-Hypoglycaemia1* when used with metformin and SGLT2ia, decreased appetite1
The warning signs of low blood sugar may come on suddenly. They can include: cold sweat, cool pale skin, headache, fast heartbeat, feeling sick (nausea) or very hungry, changes in vision, feeling sleepy or weak, feeling nervous, anxious or confused, difficulty concentrating or shaking.
Low blood sugar is more likely to happen if you also take a sulfonylurea or insulin. Your doctor may reduce your dose of these medicines before you start using this medicine.
Rare: may affect up to 1 in 1,000 people
Severe allergic reactions (anaphylactic reactions, angioedema). You should seek immediate emergency medical help if you get symptoms such as feeling dizzy or weak, breathing problems, swelling of the lips, face, tongue, and/or throat, along with difficulty swallowing, wheezing, a fast heartbeat, cold and pale skin.
OTHER POTENTIAL, RARE SIDE EFFECTS:
Gallbladder Issues: Mounjaro has the potential to cause problems with the gallbladder, such as gallstones. Some cases might necessitate surgical intervention. Symptoms to watch for include upper abdominal pain, fever, skin or eye yellowing (jaundice), or coloured stools.
Kidney Problems (Kidney Failure): In individuals with pre-existing kidney issues, side effects like diarrhoea, nausea, and vomiting may lead to dehydration, worsening kidney problems. It's crucial to stay hydrated to minimise this risk.
Increased Heart Rate: Mounjaro can cause an elevated heart rate at rest. If you notice your heart racing or pounding in your chest for several minutes, inform your healthcare provider.
CAN I DRIVE WHILST TAKING MOUNJARO?
Yes. However, if you are diabetic and using this medicine in combination with a sulfonylurea or insulin, low blood sugar (hypoglycaemia) may occur, which may reduce your ability to concentrate. Do not drive or use machines if you get any signs or symptoms of low blood sugar.
CAN I DRINK ALCOHOL WHILST TAKING MOUNJARO?
Consuming alcohol while on Mounjaro is generally permissible as there are no known direct interactions between the two. However, it's important to note that both alcohol and Mounjaro can lead to lower blood sugar levels. As a result, it's wise to closely observe your body's response to the medication, especially if you experience symptoms like lightheadedness or dizziness.
WHAT IF I AM ALREADY TAKING ANOTHER WEIGHT LOSS MEDICATION?
MOUNJARO should not be used in combination with other semaglutide-containing products, or any other GLP-1 receptor agonist (1). The safety and efficacy of co-administration with other weight loss products has not been established.
WHAT LONG CAN I TAKE MOUNJARO FOR?
Mounjaro is safe and approved by the Medicines and Healthcare Regulatory Agency (MHRA) for long term use, for weight management and weight loss, as long as it remains beneficial.
IS MOUNJARO ADDICTIVE?
There is no evidence that Mounjaro is addictive.
DO I NEED A PRECRIPTION?
Yes. Mounjaro is a prescription only medicine. Once you have completed your Mounjaro form, our medical professional will assess suitability, and prescribe and dispense your treatment if you are medically suitable.
DO I NEED TO COME INTO CLINIC?
You are welcome to do so, but you do not have to. We have developed and launched an interactive screening tools, which takes into account your medical history and assesses your suitability for Mounjaro. This is then reviewed by our prescriber, and if suitable, will be dispensed and then delivered to your address.
WHAT IF I HAVE OTHER QUESTIONS THAT AREN'T ANSWERED ON HERE?
If you have any other questions or need any help at all, please email us. You can email us by clicking here.
